Ceftiofur use in finishing swine barns and the recovery of fecal Escherichia coli or Salmonella spp. Resistant to ceftriaxone

Foodborne Pathogens and Disease

Volumn 8, Issue 11, 2011, Pages 1229-1234

  Lutz, Eric A ^a   McCarty, Marlena J ^b   Mollenkopf, Dixie F ^b   Funk, Julie A ^c   Gebreyes, Wondwossen A ^b   Wittum, Thomas E ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE AMPC; CEFAZOLIN; CEFOTAXIME PLUS CLAVULANIC ACID; CEFOXITIN; CEFPODOXIME; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; KANAMYCIN; MEROPENEM; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; ESCHERICHIA COLI; FECES ANALYSIS; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA; SWINE; ANIMAL; ANIMAL SALMONELLOSIS; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; FECES; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; STATISTICAL MODEL; SWINE DISEASE; UNITED STATES; VETERINARY;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; SALMONELLA; SUIDAE;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; LOGISTIC MODELS; MICROBIAL SENSITIVITY TESTS; NORTH CAROLINA; SALMONELLA; SALMONELLA INFECTIONS, ANIMAL; SWINE; SWINE DISEASES;

EID: 80155174950     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2011.0925     Document Type: Article

References (28)

1. Alali WQ, Scott HM, Norby B, Gebreyes W, and Loneragan GH. Quantification of the bla(CMY-2) in feces from beef feedlot cattle administered three different doses of ceftiofur in a longitudinal controlled field trial. Foodborne Pathog Dis 2009;6:917-924.
2. Alexander TW, Reuter T, Sharma R, Yanke LJ, Topp E, and McAllister TA. Longitudinal characterization of resistant Escherichia coli in fecal deposits from cattle fed subtherapeutic levels of antimicrobials. Appl Environ Microbiol 2009;75: 7125-7134.
3. Alexander TW, Yanke LJ, Topp E, Olson ME, Read RR, Morck DW, and McAllister TA. Effect of subtherapeutic administration of antibiotics on the prevalence of antibiotic-resistant Escherichia coli bacteria in feedlot cattle. Appl Environ Micro-biol 2008;74:4405-4416. (Pubitemid 352031022)
4. Bayardelle P and M Zafarullah. Development of oligonucleotide primers for the specific PCR-based detection of the most frequent Enterobacteriaceae species DNA using wec gene templates. Can J Microbiol 2002;48:113-122. (Pubitemid 34258636)
5. Bonnet C, Diarrassouba F, Brousseau R, Masson L, Topp E, and Diarra MS. Pathotype and antibiotic resistance gene distributions of Escherichia coli isolates from broiler chickens raised on antimicrobial-supplemented diets. Appl Environ Microbiol 2009;75:6955-6962.
6. [CLSI] Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 8th edition. CLSI Document M07-A8. Wayne, PA, 2008.
7. Daniels JB, Call DR, Hancock D, Sischo WM, Baker K, and Besser TE. Role of ceftiofur in selection and dissemination of blaCMY-2-mediated cephalosporin resistance in Salmonella enterica and commensal Escherichia coli isolates from cattle. Appl Environ Microbiol 2009;75:3648-3655.
8. [FDA] U.S. Food and Drug Administration, Centers for Veterinary Medicine. Guidance for Industry #152-Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern, October 23, 2003. 2009. Available at www.fda.gov/downloads/ AnimalVeterinary/GuidanceComplianceEnforce-ment/GuidanceforIndustry/ucm052519. pdf, accessed 4/7/2011. (Online.)
9. Funk JA, LeJeune JT, Wittum TE, and Rajala-Schultz P. The effect of subtherapeutic chlortetracycline on antimicrobial resistance in the fecal flora of swine. Microb Drug Resist 2006;12:210-218. (Pubitemid 44784046)
10. Heider LC, Funk JA, Hoet AE, Meiring RW, Gebreyes WA, and Wittum TE. Identification of Escherichia coli and Salmonella enterica organisms with reduced susceptibility to ceftriaxone from fecal samples of cows in dairy herds. Am J Vet Res 2009;70:389-393.
11. Jiang X, Yang H, Dettman B, and Doyle MP. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathog Dis 2006;3:355-365. (Pubitemid 46106311)
12. Jørgensen CJ, Cavaco LM, Hasman H, Emborg HD, and Guar-dabassi L. Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur. J Antimicrob Chemother 2007; 59:1040-1042. (Pubitemid 47073385)
13. Lefebvre B, Diarra MS, Moisan H, and Malouin F. Detection of virulence-associated genes in Escherichia coli O157 and non-O157 isolates from beef cattle, humans, and chickens. J Food Protect 2008;174:1774-1784.
14. Lowrance TC, Loneragan GH, Kunze DJ, Platt TM, Ives SE, Scott HM, Norby B, Echeverry A, and Brashears MM. Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. Am J Vet Res 2007;68:501-507. (Pubitemid 46824932)
15. Mann S, Siler JD, Jordan D, and Warnick LD. Antimicrobial susceptibility of fecal Escherichia coli isolates in dairy cows following systemic treatment with ceftiofur or penicillin. Foodborne Pathog Dis 2011;8:861-867.
16. Phillips I, Casewell M, Cox T, De Groot B, Friis C, Jones R, Nightingale C, Preston R, and Waddell J. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 2004;53:28.
17. Powers JH. Use and Importance of Cephalosporins in Human Medicine. Report to the US FDA Fall 2006 Veterinary Medicine Advisory Committee. 2010. Available at www.fda .gov/AdvisoryCommittees/CommitteesMeetingMaterials/ VeterinaryMedicineAdvisoryCommittee/ucm129875.htm, accessed 4/7/2011. (Online.)
18. Rankin SC, Aceto H, Cassidy J, Holt J, Young S, Love B, Tewari D, Munro DS, and Benson CE. Molecular characterization of cephalosporin-resistant Salmonella enterica Serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol 2002;40:4679-4684. (Pubitemid 35434967)
19. Rupp ME and Fey PD. Extended spectrum beta-lactamase (ESBL)-producing enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003;63: 353-365. (Pubitemid 36259523)
20. Singer RS, Patterson SK, and Wallace RL. Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract. Appl Environ Microbiol 2008; 74:6956-6962.
21. Tian GB, Wang HN, Zou LK, Tang JN, Zhao YW, Ye MY, Tang JY, Zhang Y, Zhang AY, Yang X, Xu CW, and Fu YJ. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog Dis 2009;6:297-304.
22. Tragesser LA, Wittum TE, Funk JA, Winokur PL, and Rajala-Schultz PJ. Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am J Vet Res 2006;67:1696-1700. (Pubitemid 44605286)
23. [USDA] U.S. Department of Agriculture. Swine 2006, Part II: Reference of Swine Health and Health Management Practices in the United States, 2006. #N479.1207. USDA APHIS VS CEAH. Fort Collins, CO, 2007.
24. [USDA] U.S. Department of Agriculture. Dairy 2007, Part III: Reference of Dairy Cattle Health and Management Practices in the United States, 2007. #N482.0908. USDA APHIS VS CEAH. Fort Collins, CO, 2008.
25. Wagner BA, Straw BE, Fedorka-Cray PJ, and Dargatz DA. Effect of antimicrobial dosage regimen on Salmonella and Escherichia coli isolates from feeder swine. Appl Environ Microbiol 2008; 74:1731-1739. (Pubitemid 351400127)
26. [WHO] World Health Organization. Critically important antimicrobials for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use. Report of the 2nd WHO expert meeting (Copenhagen, Denmark), 29-31 May 2007.
27. Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, and Doern GV. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother 2000;44:2777-2783.
28. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, and Doern GV. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001;45:2716-2722. (Pubitemid 32906662)